Sponsorships, Pricing of Public Offering, and Investor Meetings - Research Report on Lilly, Mallinckrodt, Integra, and NuVasive Editor Note: For more information about this release, please scroll to bottom. PR Newswire NEW YORK, November 11, 2013 NEW YORK, November 11, 2013 /PRNewswire/ -- Today, Analysts' Corner announced new research reports highlighting Eli Lilly & Co. (NYSE: LLY), Mallinckrodt plc (NYSE: MNK), Integra Lifesciences Holdings Corp. (NASDAQ: IART), Allscripts Healthcare Solutions Inc. (NASDAQ: MDRX), and NuVasive, Inc. (NASDAQ: NUVA). Today's readers may access these reports free of charge - including full price targets, industry analysis and analyst ratings - via the links below. Eli Lilly & Co. Research Report On November 1, 2013, Lilly Diabetes, part of Eli Lilly & Co. (Lilly), and Medtronic, Inc. (Medtronic) announced that they have teamed up to serve as first ever national presenting sponsors of this season's JDRF Walk to Cure Diabetes. According to Lilly, as national presenting sponsors, Lilly Diabetes and Medtronic will host educational booths at select local events and will work with their employees to form Walk teams at each location. The Companies expect the sponsorship to help JDRF fund more than half a million dollars for type 1 diabetes (T1D) research. Mike Mason, Vice President, U.S., Lilly Diabetes, said, "Sponsoring the JDRF Walk to Cure Diabetes is an important milestone in Lilly's partnership with Medtronic and means a lot to our employees. Every day we strive to support people living with diabetes in their journeys with the disease. Sponsoring the JDRF Walk to Cure Diabetes will provide support the day of the walk and for years to come by helping JDRF further its important work in diabetes research and advocacy." The Companies expect 2014 Walks to begin around the U.S. on January 25, 2013. The Full Research Report on Eli Lilly & Co. - including full detailed breakdown, analyst ratings and price targets - is available to download free of charge at: [http://www.analystscorner.com/r/full_research_report/977d_LLY] -- Mallinckrodt plc Research Report On November 6, 2013, Mallinckrodt plc (Mallinckrodt), along with Pharmachemical Ireland, announced that as part of 2013 Science Week, the Company has extended an invitation to schools to win scientific equipment by participating in a poster competition. The theme of the competition is "What Does Chemistry Mean in My Everyday Life?" and it is open to first-year students in secondary schools in Dublin 15/County Meath area, with the first place prize being €2500 worth of scientific equipment; second- and third-place winners will receive equipment valued at €1000 and €500, respectively. The last date to submit the entries is December 20, 2013. Mallinckrodt further reported that the posters will be judged on the basis of design, content and presentation. The Full Research Report on Mallinckrodt plc - including full detailed breakdown, analyst ratings and price targets - is available to download free of charge at: [http://www.analystscorner.com/r/full_research_report/24f6_MNK] -- Integra Lifesciences Holdings Corp. Research Report On November 6, 2013, Integra LifeSciences Holdings Corporation (Integra) announced that the Company has priced its previously announced underwritten public offering of 3.5 million shares of its common stock at $40.00 per share. Further, Integra has also granted the underwriters a 30-day option to purchase an additional 525,000 shares of common stock. Integra informed that it intends to use the net proceeds from the offering, including any net proceeds received from an exercise of the underwriters' option to purchase additional shares, for general corporate purposes which may include reducing outstanding borrowings under Integra's senior credit facility and paying a portion of the purchase price for the proposed acquisition by Integra Lifesciences Corporation, the Company's wholly-owned subsidiary, of Cofluent Surgical, Inc., including its DuraSeal product line. The Company expects the offering to close on November 13, 2013, subject to customary closing conditions. The Full Research Report on Integra Lifesciences Holdings Corp. - including full detailed breakdown, analyst ratings and price targets - is available to download free of charge at: [http://www.analystscorner.com/r/full_research_report/c0a4_IART] -- Allscripts Healthcare Solutions Inc. Research Report On November 1, 2013, Allscripts Healthcare Solutions Inc. (Allscripts) announced that HealthCare Partners, LLC (HealthCare Partners) will expand its nationwide partnership with the Company by further deploying the Allscripts Enterprise Electronic Health Record (EHR) across its California medical group sites and selecting the FollowMyHealth patient portal and the dbMotion population health management solution. According to the Company, Allscripts Enterprise is a robust solution for large, multi-specialty practices with some of the most advanced features on the market. Further, Allscripts informed that FollowMyHealth is a patient engagement solution that combines the value of a personal health record, online patient portal, and the connectivity and sharing of data that comes within a community of health. Paul M. Black, CEO of Allscripts, said, "The combination of our Open Electronic Health Record, patient engagement portal and community interoperability solutions will empowerHealthCare Partnersto continue as a leader in this evolving healthcare environment and better manage population health for the communities it serves." The Full Research Report on Allscripts Healthcare Solutions Inc. - including full detailed breakdown, analyst ratings and price targets - is available to download free of charge at: [http://www.analystscorner.com/r/full_research_report/1787_MDRX] -- NuVasive, Inc. Research Report On November 4, 2013, NuVasive, Inc. (NuVasive) announced that it will host a meeting for investors and analysts at NuVasive East office, 117 West Century Road, Paramus, New Jersey, 07652, on November 14, 2013, from 8:30 a.m. ET to 11:00 a.m. ET. The Company reported that several senior members of the executive team will come together to provide an in-depth progress report on the top drivers of NuVasive's strategy for sustained growth with increasing profitability. The Full Research Report on NuVasive, Inc. - including full detailed breakdown, analyst ratings and price targets - is available to download free of charge at: [http://www.analystscorner.com/r/full_research_report/c66c_NUVA] ---- EDITOR NOTES: 1.This is not company news. We are an independent source and our views do not reflect the companies mentioned. 2.Information in this release is fact checked and produced on a best efforts basis and reviewed by Ananya Ghosh, a CFA charterholder. However, we are only human and are prone to make mistakes. If you notice any errors or omissions, please notify us below. 3.This information is submitted as a net-positive to companies mentioned, to increase awareness for mentioned companies to our subscriber base and the investing public. 4.If you wish to have your company covered in more detail by our team, or wish to learn more about our services, please contact us at pubco@EquityNewsNetwork.com. 5.For any urgent concerns or inquiries, please contact us at compliance@EquityNewsNetwork.com. 6.Are you a public company? Would you like to see similar coverage on your company? Send us a full investors' package to research@EquityNewsNetwork.com for consideration. COMPLIANCE PROCEDURE Content is researched, written and reviewed on a best-effort basis. This document, article or report is prepared and authored by Equity News Network. An outsourced research services provider represented by Ananya Ghosh, CFA, has only reviewed the information provided by Equity News Network in this article or report according to the Procedures outlined by Equity News Network. Equity News Network is not entitled to veto or interfere in the application of such procedures by the outsourced provider to the articles, documents or reports, as the case may be. NOT FINANCIAL ADVICE Equity News Network makes no warranty, expressed or implied, as to the accuracy or completeness or fitness for a purpose (investment or otherwise), of the information provided in this document. This information is not to be construed as personal financial advice. Readers are encouraged to consult their personal financial advisor before making any decisions to buy, sell or hold any securities mentioned herein. NO WARRANTY OR LIABILITY ASSUMED Equity News Network is not responsible for any error which may be occasioned at the time of printing of this document or any error, mistake or shortcoming. No liability is accepted by Equity News Network whatsoever for any direct, indirect or consequential loss arising from the use of this document. Equity News Network expressly disclaims any fiduciary responsibility or liability for any consequences, financial or otherwise arising from any reliance placed on the information in this document. Equity News Network does not (1) guarantee the accuracy, timeliness, completeness or correct sequencing of the information, or (2) warrant any results from use of the information. The included information is subject to change without notice. CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute. AnalystsCorner.com SOURCE Analysts' Corner Contact: Joe Thomas, CONTACT PHONE: +1-310-496-8071 (North America)
Sponsorships, Pricing of Public Offering, and Investor Meetings - Research Report on Lilly, Mallinckrodt, Integra, and NuVasive
Press spacebar to pause and continue. Press esc to stop.